1460880818-5b33df38-281a-4416-ad44-e506ed6c4895

1. A method of treating andor preventing neuropathy, or neuropathy and ulcers resulting from said neuropathy, comprising identifying an individual having neuropathy, or neuropathy and ulcers resulting from said neuropathy; and administering a therapeutically effective amount of nitric oxide (NO) to said individual.
2. The method of claim 1, wherein said neuropathy is diabetic peripheral neuropathy.
3. A non-implantable device for treating andor preventing neuropathy, or neuropathy and ulcers resulting from said neuropathy, at a target site of a body, wherein
said device comprises a nitric oxide (NO) eluting polymer configured to elute a therapeutic dosage of nitric oxide (NO) when used for said treatment andor prevention, and wherein said device is configured for exposure of said target site on a body to said nitric oxide when said polymer elutes nitric oxide (NO), wherein
said nitric oxide (NO) eluting polymer is integrated with a carrier material, which regulates and controls the elution of said therapeutic dosage of nitric oxide (NO), and wherein said device includes a proton donor bag, sealed proton donor sponge, or microencapsulated proton donor.
4. The device according to claim 3, wherein said elution of nitric oxide (NO) from said device is substantially directed towards said target site for said exposure.
5. The device according to claim 4, further comprising a first membrane which is permeable to nitric oxide on a first side of the device, wherein said first side is oriented towards said treatment site, and a second membrane which has low permeability or substantially no permeability to nitric oxide on a second side of said device, wherein said second side is oriented away from said treatment site, wherein said substantial direction of nitric oxide (NO) from said device is provided as the elution of nitric oxide from said device and is substantially prevented from said second side.
6. The device according to claim 3, wherein said nitric oxide (NO) eluting polymer comprises diazeniumdiolate groups, S-nitrosylated groups, O-nitrosylated groups, or any combination thereof.
7. The device according to claim 6, wherein said nitric oxide (NO) eluting polymer is L-PEI (linear polyethyleneimine).
8. The device according to claim 6, wherein said nitric oxide eluting polymer is selected from the group consisting of amino cellulose, amino dextrans, chitosan, aminated chitosan, polyethyleneimine, PEI-cellulose, polypropyleneimine, polybutyleneimine, polyurethane, poly(buthanediol spermate), poly(iminocarbonate), polypeptide, Carboxy Methyl Cellulose (CMC), polystyrene, poly(vinyl chloride), polydimethylsiloxane, and any combination thereof, wherein said polymer is grafted to an inert backbone selected from the group consisting of a polysaccharide backbone and a cellulosic backbone.
9. The device according to claim 3, wherein said device is selected from the group consisting of a sock, a tapecoating, a patchdressing and a plaster.
10. The device according to claim 9, wherein said sock, tapecoating, or plaster is manufactured from polyethylene, polypropylene, polyacrylonitrile, polyurethane, polyvinylacetates, polylacticacids, starch, cellulose, polyhydroxyalkanoates, polyesters, polycaprolactone, polyvinylalcohol, polystyrene, polyethers, polycarbonates, polyamides, poly(acrylic acid), Carboxy Methyl Cellulose (CMC), protein based polymers, gelatine, biodegradable polymers, cotton, polyolefins, latex, or any combination thereof.
11. The device according to claim 3, wherein said device is partly disintegrable when subjected to a proton donor.
12. The device according to claim 11, wherein said proton donor is selected from the group consisting of water, blood, lymph, bile, methanol, ethanol, propanols, butanols, pentanols, hexanols, phenols, naphtols, polyols, phosphates, succinates, carbonates, acetates, formats, propionates, butyrates, fatty acids, amino acids, and any combination thereof.
13. The device according to claim 12, wherein said proton donor comprises a surfactant for facilitating wetting of the device.
14. The device according to claim 3, wherein said polymer comprises silver.
15. The device according to claim 9, wherein said NO eluting polymer enhances the effect of said patch.
16. The device according to claim 3, wherein said nitric oxide eluting polymer is in form of nanoparticles or microspheres.
17. The device according to claim 16, wherein said nanoparticles or microspheres are encapsulated in a material selected from the group consisting of polyethylene, polypropylene, polyacrylonitrile, polyurethane, polyvinylacetates, polylacticacids, starch, cellulose, polyhydroxyalkanoates, polyesters, polycaprolactone, polyvinylalcohol, polystyrene, polyethers, polycarbonates, polyamides, poly(acrylic acid), Carboxy Methyl Cellulose (CMC), protein based polymers, gelatine, biodegradable polymers, cotton, polyolefins, latex, and any combination thereof.
18. The device according to claim 16, wherein said nanoparticles or microspheres are integrated in a gel, hydrogel, foam or cream.
19. The device according to claim 3, wherein said carrier material is selected from the group consisting of polyethylene, polypropylene, polyacrylonitrile, polyurethane, polyvinylacetates, polylacticacids, starch, cellulose, polyhydroxyalkanoates, polyesters, polycaprolactone, polyvinylalcohol, polystyrene, polyethers, polycarbonates, polyamides, poly(acrylic acid), Carboxy Methyl Cellulose (CMC), protein based polymers, gelatine, biodegradable polymers, cotton, polyolefins, latex and any combination thereof.
20. The device according to claim 3, wherein said nitric oxide eluting polymer comprises a secondary amine in the backbone or a secondary pendant amine.
21. The device according to claim 20, wherein a positive ligand is located on a neighbor atom to the secondary amine.
22. The device according to claim 3, further comprising an absorbent agent.
23. The device according to claim 22, wherein said absorbent agent is selected from the group consisting of polyacrylate, polyethylene oxide, Carboxy Methyl Cellulose (CMC), microcrystalline cellulose, cotton, starch, and any combination thereof.
24. The device according to claim 3, further comprising a cation, wherein said cation stabilizes the nitric oxide eluting polymer.
25. The device according to claim 24, wherein said cation is selected from the group consisting of Na+, K+, Li+, Be2+, Ca2+, Mg2+, Ba2+, Sr2+, and any combination thereof.
26. The device according to claim 3, wherein said carrier material is a hydrogel.
27. The device according to claim 3, wherein the nitric oxide eluting polymer is activatable by a proton donor, wherein the nitric oxide eluting polymer is, prior to use, stored separately from the proton donor until initiation of elution of nitric oxide therefrom.
28. The device according to claim 27, wherein the device is a syringe-type device having two separate containers, wherein a first container contains a proton donor-based NO release activation agent, and a second container contains a non proton donor-based gel comprising the nitric oxide eluting polymer, wherein the syringe-type device is configured to provide admixing upon administration to said target site.
29. A manufacturing process for a device according to claim 3 configured to therapeutically target, treat andor prevent neuropathy, or neuropathy and ulcers resulting from said neuropathy, at a target site of a body, comprising:
selecting a nitric oxide (NO) eluting polymer configured to elute a therapeutic dosage of nitric oxide (NO) when used for said therapeutic treatment andor prevention of neuropathy, or neuropathy and ulcers resulting from said neuropathy;
selecting a carrier material, said carrier material configured to regulate and control the elution of said therapeutic dosage of nitric oxide (NO);
incorporating the NO-eluting polymer with said carrier material into a nitric oxide (NO) eluting material, wherein said carrier material regulates and controls the elution of said therapeutic dosage of nitric oxide (NO);
deploying said nitric oxide eluting material into a suitable form, or as a coating onto a carrier, to form at least a part of said device, wherein said device is configured to expose a therapeutic target site to said nitric oxide when said NO-eluting polymer in use elutes nitric oxide (NO); and
applying a proton donor bag, sealed proton donor sponge, or microencapsulated proton donor to said device.
30. The manufacturing method according to claim 29, further comprising applying a material that has low permeability or substantially no permeability to nitric oxide (NO) on a side of device that is intended to be oriented away from said therapeutic target site, wherein elution of nitric oxide is substantially directed towards said therapeutic target site.
31. The manufacturing process according to claim 29, wherein said deploying comprises electro spinning, air spinning, gas spinning, wet spinning, dry spinning, melt spinning, or gel spinning of said NO-eluting polymer.
32. The manufacturing process according to claim 29, wherein said selecting said nitric oxide (NO) eluting polymer comprises selecting a plurality of nitric oxide (NO) eluting polymeric particles selected from the group consisting of nanofibers, nanoparticles and microspheres.
33. The manufacturing process according to claim 29, wherein said incorporating said NO-eluting polymer with said carrier material comprises integrating said NO-eluting polymer in said carrier material, spinning said NO-eluting polymer together with said carrier material, or spinning said NO-eluting polymer on top of said carrier material.
34. The manufacturing process according to claim 29, further comprising integrating silver into said device.
35. The manufacturing process according to claim 29, wherein said applying a microencapsulated proton donor to said device comprises
microencapsulating a proton donor in microcapsules; and
applying the microcapsules to said nitric oxide (NO) eluting material.
36. The manufacturing process according to claim 35, wherein said applying comprises pattern gluing or spinning the NO eluting material onto said microcapsules.
37. The manufacturing process according to claim 35, comprising:
forming the microcapsules into a first film, tape, or sheath;
forming a second film, tape, or sheath of said NO eluting material; and
gluing the first film, tape, or sheath of microcapsules to said second film, tape, or sheath of said NO eluting material.
38. The manufacturing process according to claim 37, wherein said gluing comprises patterned gluing, wherein a pattern is obtained that includes glue-free spaces.
39. The manufacturing process according to claim 35, further comprising forming the microcapsules into a first film, tape, or sheath, and directly spinning the NO eluting material onto the film, tape, or sheath of microcapsules, wherein said film, tape or sheath contains a proton donor.
40. The manufacturing process according to claim 39, further comprising providing an activation indicator configured to indicate when the microcapsules are broken wherein the NO eluting material is subjected to said proton donor to elute NO therefrom.
41. The manufacturing process according to claim 40, wherein said providing an activation indicator comprises providing a coloring agent inside the microcapsules.
42. The manufacturing process according to claim 40, wherein said providing an activation indicator comprises selecting a material for the microcapsules, or choosing a wall thickness of said microcapsules, that creates a sound when the microcapsules break.
43. The manufacturing process according to claim 40, wherein said providing an activation indicator comprises admixing a scent material into the microcapsules.
44. The manufacturing process according to claim 40, wherein said providing an activation indicator comprises providing a substance that changes color when it comes in contact with the proton donor.
45. A device for the treatment of neuropathy, or neuropathy and ulcers resulting from said neuropathy, comprising a nitric oxide (NO) eluting polymer, wherein nitric oxide is eluted from said device as nitric oxide (NO) from said NO eluting polymer in a therapeutic dose when used at a target site of a body.
46. The device according to claim 45, wherein said therapeutic dose is 0.001 to 5000 ppm.
47. A method of treating andor preventing neuropathy, or neuropathy and ulcers resulting from said neuropathy, at a treatment site of a body, comprising exposing a treatment site of said neuropathy in or on a body to nitric oxide with a device that comprises a nitric oxide (NO) eluting polymer configured for eluting a therapeutic dosage of nitrogen oxide (NO) to said treatment site.
48. The method according to claim 47, wherein said site is an extremity of a body, and wherein said method comprises applying a condomsheath, sock, patchpaddressing, andor tapecoating to said extremity.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method comprising:
communicating, by at least one server device, with a plurality of digital content devices associated with a user, wherein the plurality of digital content devices comprises a first digital content device and a second digital content device;
obtaining information associated with a presentation of digital content by the first digital content device, wherein the information associated with the presentation of the digital content by the first digital content device comprises a current position of the presentation of the digital content by the first digital content device; and
sending an indication of the current position to the second digital content device to enable a continued presentation of the digital content by the second digital content device beginning from the current position.
2. The method of claim 1, wherein the digital content comprises at least one of audio content, video content or text.
3. The method of claim 1, wherein the first digital content device comprises an audio player or a video player, and wherein the second digital content device comprises an audio player or a video player.
4. The method of claim 1, wherein each of the first digital content device and the second digital content device comprises one of a computer, a handheld player, an automotive player, a stand-alone player, a rack player, or a television.
5. The method of claim 1, wherein the current position represents a presentation position when the user stopped the presentation of the digital content by the first digital content device.
6. The method of claim 1, wherein the current position represents an elapsed time of the presentation of the digital content by the first digital content device.
7. The method of claim 1, further comprising detecting a disruption in the presentation of the digital content by the second digital content device.
8. The method of claim 7, wherein detecting a disruption in the presentation of the digital content comprises detecting a communication signal loss between the at least one server device and the second digital content device.
9. The method of claim 8, further comprising updating, by the at least one server device within a database, the current position to represent a position of the presentation at the time of the disruption.
10. The method of claim 9, further comprising:
reestablishing a connection with the second digital content device; and
upon reestablishing the connection with the second digital content device, sending the updated current position to the second digital content device to enable a continued presentation of the digital content by the second digital content device beginning from the updated current position.
11. A system comprising:
at least one processor; and
a non-transitory computer readable medium storing instructions that, when executed by the at least one processor, cause the at least one processor to:
maintain, by at least one server device, a record of a plurality of digital content devices associated with a user, wherein the plurality of digital content devices comprises a first digital content device and a second digital content device;
receive, from the first digital content device, information associated with a presentation of digital content by the first digital content device, wherein the information associated with the presentation of the digital content by the first digital content device comprises a current position of the presentation of the digital content by the first digital content device; and
send the current position to the second digital content device to enable a continued presentation of the digital content by the second digital content device beginning from the current position.
12. The system of claim 11, wherein the digital content comprises at least one of audio content, video content or text.
13. The system of claim 11, further comprising instructions that, when executed by the at least one processor, cause the at least one processor to detect a disruption in the presentation of the digital content.
14. The system of claim 13, further comprising instructions that, when executed by the at least one processor, cause the at least one processor to update the current position to represent a position of the presentation at the time of the disruption.
15. The system of claim 14, further comprising instructions that, when executed by the at least one processor, cause the at least one processor to:
detect a reestablished connection with the second digital content device; and
upon detecting a reestablished connection with the second digital content device, send the updated current position to the second digital content device to enable a continued presentation of the digital content by the second digital content device beginning from the updated current position.
16. A method comprising:
receiving, at a first digital content device from a user, a request to present digital content to the user;
receiving information associated with a presentation of the digital content by a second digital content device associated with the user, wherein the information associated with the presentation of the digital content by the second digital content device comprises a current position of the presentation of the digital content by the second digital content device; and
presenting, by the first digital content device, the digital content beginning from the current position.
17. The method of claim 16, wherein the digital content comprises at least one of audio content, video content or text.
18. The method of claim 16, wherein each of the first digital content device and the second digital content device comprises a computer, a handheld player, an automotive player, a stand-alone player, a rack player, or a television.
19. The method of claim 16, wherein the current position of the presentation of the digital content comprises a position other than a start point of the digital content.
20. The method of claim 16, further comprising updating the current position of the presentation of the digital content based on the presentation, by the first digital content device, of the digital content.
21. The method of claim 20, further comprising sending, by the first digital content device, the updated current position to at least one other device.
22. The method of claim 16, further comprising detecting a disruption in the presentation of the digital content by the first digital content device.
23. The method of claim 22, wherein detecting a disruption in the presentation of the digital content comprises detecting a communication signal loss.
24. The method of claim 23, further comprising updating the current position to represent a position of the presentation at the time of the disruption.
25. The method of claim 24, further comprising:
reestablishing a connection; and
upon reestablishing the connection, presenting, by the first digital content device, the digital content beginning from the updated current position.